Restasis (Allergan Inc) en es it fr

Restasis (Allergan Inc) Brand names, Restasis (Allergan Inc) Analogs

Restasis (Allergan Inc) Brand Names Mixture

  • No information avaliable

Restasis (Allergan Inc) Chemical_Formula

C62H111N11O12

Restasis (Allergan Inc) RX_link

http://www.rxlist.com/cgi/generic3/restasis.htm

Restasis (Allergan Inc) fda sheet

Restasis_(Allergan_Inc) FDA

Restasis (Allergan Inc) msds (material safety sheet)

Restasis (Allergan Inc) Synthesis Reference

No information avaliable

Restasis (Allergan Inc) Molecular Weight

1202.61

Restasis (Allergan Inc) Melting Point

No information avaliable

Restasis (Allergan Inc) H2O Solubility

No information avaliable

Restasis (Allergan Inc) State

Liquid

Restasis (Allergan Inc) LogP

4.293

Restasis (Allergan Inc) Dosage Forms

Capsule (liquid-filled); Capsule (liquid-filled for emulsion); Solution (oral); Solution (IV infusion)

Restasis (Allergan Inc) Indication

For treatment of transplant rejection, rheumatoid arthritis, severe psoriasis

Restasis (Allergan Inc) Pharmacology

Used in immunosuppression for prophylactic treatment of organ transplants, cyclosporine exerts specific and reversible inhibition of immunocompetent lymphocytes in the G0-or G1-phase of the cell cycle. T-lymphocytes are preferentially inhibited. The T1-helper cell is the main target, although the T1-suppressor cell may also be suppressed. Sandimmune (cyclosporine) also inhibits lymphokine production and release including interleukin-2.

Restasis (Allergan Inc) Absorption

No information avaliable

Restasis (Allergan Inc) side effects and Toxicity

No information avaliable

Restasis (Allergan Inc) Patient Information

BIOD00003.html

Restasis (Allergan Inc) Organisms Affected

Humans and other mammals